Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Applied Therapeutics Inc. (APLT)  
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 77,230,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $0 - $0
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Applied Therapeutics is a clinical-stage biopharmaceutical company developing a pipeline of product candidates against validated molecular targets in indications of high unmet medical need. AT-007 is a central nervous system penetrant ARI that Co. is developing for the treatment of metabolic diseases, including Galactosemia, a pediatric metabolic disease that affects how the body processes a simple sugar called galactose. AT-001 is an ARI with systemic exposure and peripheral nerve permeability that Co. is developing for the treatment of diabetic cardiomyopathy. AT-003 is an ARI designed to cross through the back of the eye when dosed orally for the treatment of diabetic retinopathy.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 30,000 30,000 3,691,409
Total Buy Value $0 $65,367 $65,367 $3,658,451
Total People Bought 0 1 1 3
Total Buy Transactions 0 1 1 5
Total Shares Sold 506,975 1,088,491 1,224,775 1,252,098
Total Sell Value $2,732,596 $4,098,859 $4,466,825 $4,492,358
Total People Sold 4 6 6 7
Total Sell Transactions 4 11 14 18
End Date 2024-01-18 2023-10-17 2023-04-18 2022-04-18

   
Records found: 243
  Page 1 of 10  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Hooks Corwin Dale Chief Commercial Officer   •       •      –    2024-04-12 4 A $0.00 $0 D/D 300,000 300,000     -
   Perfetti Riccardo Chief Medical Officer   •       –      –    2024-03-14 4 S $5.39 $597,234 D/D (110,804) 1,031,537     -
   Funtleyder Leslie D. Chief Financial Officer   •       •      –    2024-03-14 4 S $5.39 $154,839 D/D (28,727) 308,421     -
   Hansard Adam Chief Commercial Officer   •       –      –    2024-03-14 4 S $5.39 $263,415 D/D (48,871) 732,919     -
   Shendelman Shoshana President and CEO   •       •       •   2024-03-14 4 S $5.39 $1,717,108 D/D (318,573) 3,817,814     -
   Chinoporos Constantine See Remarks   •       –      –    2023-12-28 4 A $0.00 $0 D/D 300,000 300,000     -
   Hansard Adam Chief Commercial Officer   •       –      –    2023-12-21 4 A $0.00 $0 D/D 400,000 781,790     -
   Shendelman Shoshana President and CEO   •       •       •   2023-12-21 4 A $0.00 $0 D/D 1,540,000 4,136,387     -
   Perfetti Riccardo Chief Medical Officer   •       –      –    2023-12-21 4 A $0.00 $0 D/D 450,000 1,142,341     -
   Kanter Stacy J. Director   –       •      –    2023-12-01 4 B $2.18 $65,367 D/D 30,000 63,000 2.39     -
   Perfetti Riccardo Chief Medical Officer   •       –      –    2023-11-30 4 S $1.97 $3,119 D/D (1,583) 692,341     -
   Hansard Adam Chief Commercial Officer   •       –      –    2023-11-30 4 S $1.97 $1,901 D/D (965) 381,790     -
   Shendelman Shoshana President and CEO   •       •       •   2023-11-30 4 S $1.97 $7,817 D/D (3,968) 2,596,387     -
   Alexandria Venture Investments, Llc 10% Owner   –       –       •   2023-11-29 4 D $0.00 $0 I/I (575,000) 203,977     -
   Alexandria Venture Investments, Llc 10% Owner   –       –       •   2023-11-29 4 A $0.00 $0 I/I 575,000 6,155,077     -
   Funtleyder Leslie D. Chief Financial Officer   •       •      –    2023-11-20 4 A $0.00 $0 D/D 300,000 337,148     -
   Alexandria Venture Investments, Llc 10% Owner   –       –       •   2023-11-03 4 S $2.31 $331,370 I/I (143,450) 5,580,077     -
   Alexandria Venture Investments, Llc 10% Owner   –       –       •   2023-11-02 4 S $2.32 $240,835 I/I (103,808) 5,723,527     -
   Alexandria Equities No. 7, Llc 10% Owner   –       –       •   2023-11-01 4 S $2.36 $407,671 I/I (172,742) 5,827,335     -
   Alexandria Equities No. 7, Llc 10% Owner   –       –       •   2023-10-31 4 S $2.41 $373,550 I/I (155,000) 6,000,077     -
   Alexandria Equities No. 7, Llc 10% Owner   –       –       •   2023-10-12 4 D $0.00 $0 I/I (1,600,000) 778,977     -
   Alexandria Equities No. 7, Llc 10% Owner   –       –       •   2023-10-12 4 A $0.00 $0 I/I 1,600,000 6,155,077     -
   Shendelman Shoshana President and CEO   •       •       •   2023-09-27 4 S $2.70 $312,206 D/D (115,632) 2,600,355     -
   Hansard Adam Chief Commercial Officer   •       –      –    2023-09-27 4 S $2.70 $26,244 D/D (9,720) 382,755     -
   Perfetti Riccardo Chief Medical Officer   •       –      –    2023-09-27 4 S $2.70 $29,516 D/D (10,932) 693,924     -
  243 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 10
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us